See All Slides - tctmd.com

Slides

Presentation NY Valves 2024

You are Both Wrong, Engineers Hold the Key to Our Future and the Best Valve Design is Yet to be Found

Presenter: Ajit P. Yoganathan

June 06, 2024

Presentation NY Valves 2024

Will New VHD Screening Methods Address or Exacerbate Healthcare Disparities?

Presenter: Suzanne J. Baron

June 06, 2024

Presentation NY Valves 2024

SAVR for the Small Annulus Patient – Surgical Trends and Perspectives

Presenter: Hendrik Treede

June 06, 2024

Presentation NY Valves 2024

J-Valve

Presenter: Santiago Garcia

June 06, 2024

Presentation NY Valves 2024

Asymmetric Expansion of Balloon Expandable Transcatheter Aortic Valve Prostheses: Implications for Valve Hemodynamics and Clinical Outcomes

Presenter: Annette Maznyczka

June 06, 2024

Presentation NY Valves 2024

Determinants of Intervention Type and All-Cause Mortality of TAVR and SAVR Patients Younger Than 75 Years in the Netherlands

Presenter: Nicolas M. Van Mieghem

June 06, 2024

Presentation NY Valves 2024

SAVR Will Have a Longer Lasting Durability Than TAVR

Presenter: Stephan Windecker

June 06, 2024

Presentation NY Valves 2024

TAV-in-TAV With a 23mm SAPIEN3 Ultra Resilia in a Degenerated 23mm SAPIEN3 Valve

Presenter: Supawat Ratanapo

June 06, 2024

Presentation NY Valves 2024

Introducing Novel Transcatheter Tricuspid Therapies: What Can the Early European Experience With TTVI Teach Us?

Presenter: Jörg Hausleiter

June 06, 2024

Presentation NY Valves 2024

TMVR Following Failed M-TEER: Technical and Procedural Considerations

Presenter: Rodrigo D. Estevez-Loureiro

June 06, 2024

Advertisement

Slides

You are Both Wrong, Engineers Hold the Key to Our Future and the Best Valve Design is Yet to be Found

Will New VHD Screening Methods Address or Exacerbate Healthcare Disparities?

SAVR for the Small Annulus Patient – Surgical Trends and Perspectives

J-Valve

Asymmetric Expansion of Balloon Expandable Transcatheter Aortic Valve Prostheses: Implications for Valve Hemodynamics and Clinical Outcomes

Determinants of Intervention Type and All-Cause Mortality of TAVR and SAVR Patients Younger Than 75 Years in the Netherlands

SAVR Will Have a Longer Lasting Durability Than TAVR

TAV-in-TAV With a 23mm SAPIEN3 Ultra Resilia in a Degenerated 23mm SAPIEN3 Valve

Introducing Novel Transcatheter Tricuspid Therapies: What Can the Early European Experience With TTVI Teach Us?

TMVR Following Failed M-TEER: Technical and Procedural Considerations

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content